Budget Impact Associated with the Introduction of the Impella 5.0(®) Mechanical Circulatory Support Device for Cardiogenic Shock in France.

Le Guyader A, Pernot M, Delmas C, Roze S, Fau I, Flecher E, Lebreton G

Open source

DOI
10.2147/ceor.s278269
Published
2021
Container
ClinicoEconomics and outcomes research : CEOR
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ceor.s278269,
  title = {Budget Impact Associated with the Introduction of the Impella 5.0(®) Mechanical Circulatory Support Device for Cardiogenic Shock in France.},
  author = {Le Guyader A and Pernot M and Delmas C and Roze S and Fau I and Flecher E and Lebreton G},
  year = {2021},
  journal = {ClinicoEconomics and outcomes research : CEOR},
  doi = {10.2147/ceor.s278269},
  url = {https://doi.org/10.2147/ceor.s278269}
}

RIS

TY  - JOUR
TI  - Budget Impact Associated with the Introduction of the Impella 5.0(®) Mechanical Circulatory Support Device for Cardiogenic Shock in France.
AU  - Le Guyader A
AU  - Pernot M
AU  - Delmas C
AU  - Roze S
AU  - Fau I
AU  - Flecher E
AU  - Lebreton G
PY  - 2021
JO  - ClinicoEconomics and outcomes research : CEOR
DO  - 10.2147/ceor.s278269
UR  - https://doi.org/10.2147/ceor.s278269
ER  - 

APA

A, L. G., M, P., C, D., S, R., I, F., E, F., & G, L. (2021). Budget Impact Associated with the Introduction of the Impella 5.0(®) Mechanical Circulatory Support Device for Cardiogenic Shock in France.. ClinicoEconomics and outcomes research : CEOR. https://doi.org/10.2147/ceor.s278269

Source records